Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003)

Vaccine

Volumn 24, Issue 16, 2006, Pages 3145-3152

  Michiels, Barbara ^a   Philips, Hilde ^a   Coenen, Samuel ^a   Denekens, Joke ^a   Van Royen, Paul ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antibodies; General practitioner; Influenza vaccine

Indexed keywords

ALFARIX; INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENERAL PRACTITIONER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; BELGIUM; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PHYSICIANS, FAMILY; STATISTICS;

EID: 33645052450     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.040     Document Type: Article

References (25)

1. S.A. Harper, K. Fukuda, T.M. Uyeki, N.J. Cox, and C.B. Bridges Prevention and Control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 54 RR-8 2005 1 40
2. G.A. Poland, P. Tosh, and R.M. Jacobson Requiring influenza vaccination for health care workers: seven truths we must accept Vaccine 23 2005 2251 2255
3. A.M. Palache, W.E. Beyer, and M.J. Sprenger Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers Vaccine 11 1 1993 3 9
4. N.W. Hehme, W. Künzel, and F. Petschke Ten years of experience with the trivalent split-influenza vaccine, Fluarix Clin Drug Invest 22 11 2002 751 769
5. D.G. Kleinbaum, and M. Klein Logistic regression 2002 Springer-Verlag New York
6. J.J. Treanor, and F.G. Hayden Volunteer challenge studies K.G. Nicholson Textbook of influenza 1998 Blackwell Science Ltd Oxford 517 537
7. V. Knight New research on influenza: studies with normal volunteers Ann Intern Med 62 6 1965 1307 1325
8. A.M. Palache, W.E.P. Beyer, G. Lüchters, R. Völker, M.J.W. Sprenger, and N. Masurel Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature Vaccine 11 9 1993 892 908
9. J.A. Wilde, J.A. McMillan, J. Serwint, J. Butta, M.A. O'Riordan, and M.C. Steinhoff Effectiveness of influenza vaccine in health care professionals. A randomized trial JAMA 281 1999 908 913
10. European Influenza Surveillance Scheme. Annual report: 2002-2003 influenza season. NIVEL, Utrecht, The Netherlands, 2004.
11. European Influenza Surveillance Scheme. Annual report: 2003-2004 influenza season. NIVEL, Utrecht, The Netherlands, 2005.
12. F. Yane, M.L. Libotte, and B. Brochier Surveillance van griep in België. Seizoen 2003-2004 2004 Scientific Institute of Public Health, National Influenza Centre Brussel, België
13. K.L. Russell, M.A.K. Ryan, A. Hawksworth, N.E. Freed, M. Irvine, and L.T. Daum Effectiveness of the 2003-2004 influenza vaccine among US military basic trainees: a year of suboptimal match between vaccine and circulating strain Vaccine 23 2005 1981 1985
14. W.E.P. Beyer, I.A. de Bruijn, and A.M. Palache Protection against Influenza after annually repeated vaccination Arch Intern Med 159 1999 182 187
15. W.A. Keitel, T.R. Cate, R.B. Couch, L.L. Huggins, and K.R. Hess Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period Vaccine 15 10 1997 1114 1122
16. W. Künzel, H. Glathe, H. Engelmann, and V.H. Ch Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time Vaccine 14 12 1996 1108 1110
17. U. Gulati, K. Kumari, and W. Wu Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination Vaccine 23 2005 1414 1425
18. A.S. Monto, and K.M. Sullivan Acute respiratory illness in the community: frequency of illness and the agents involved Epidemiol Infect 110 1993 145 160
19. D. Weycker, J. Edelsberg, and M.E. Halloran Population-wide benefits of routine vaccination of children against influenza Vaccine 23 2005 1284 1293
20. B. Michiels, D. Avonts, and P. Van Royen Lower incidence of the upper respiratory tract infections among general practitioners as compared to their patients Eur J Epidemiol 17 12 2002 1059 1061
21. B. Michiels, S. Coenen, D. Avonts, P. Van Royen, and J. Denekens Who benefits from an influenza vaccination of GPs? Vaccine 20 2001 1 2
22. R.F. Betts, and J.J. Treanor Approaches to improved influenza vaccination Vaccine 18 16 2000 1690 1695
23. E. Greenbaum, D. Engelhard, R. Levy, M. Schlezinger, A. Morag, and Z. Zakay-Rones Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine Vaccine 22 2004 2566 2577
24. S.A. Halperin, B. Smith, K. Clarke, J. Treanor, T. Mabrouk, and M. Germain Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults Human Vaccines 1 2005 37 42
25. M.L. Clements, R.F. Betts, and B.R. Murphy Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection Lancet 1 8379 1984 705 708